Join
Live feed
·
PRReleasevia Quantisnow
Alnylam Pharmaceuticals Inc. logo
Tenaya Therapeutics Inc. logo

Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
ALNY· Alnylam Pharmaceuticals Inc.TNYA· Tenaya Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALNY (Alnylam Pharmaceuticals Inc.), TNYA (Tenaya Therapeutics Inc.) and more on Quantisnow.